Alexza Pharmaceuticals, a pharmaceutical company, has received EU Certificate of GMP Compliance for its Adasuve manufacturing facility.
In May 2012, Alexza hosted an EU GMP inspection, which was conducted by the Agencia Espanola de Medicamentos y Productos Sanitarios.
The Spanish authorities, on behalf of the EU, from the inspection of the company’s Mountain View, California facility and additional company responses, considered that the Alexza facility complies with the principles and guidelines of Good Manufacturing Practice set forth in Directive 2003/94/EC.
The initial certificate is valid through 15 May 2015, according to Alexza Pharmaceuticals. Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.